- Goldman Sachs sees no downside risk to commodity prices despite the prospect of a banking crisis and sees an average 28% upside potential over the next 12 months;
- Despite declines in lithium prices, demand for electric cars in China remains at higher levels due to the opening up of the Chinese economy and moderately loose monetary policy in the Middle Kingdom;
- The US has implemented the Inflation-Reduction Act (IRA) programme, which could lift demand for electric cars in the US. Energy prices have fallen convincingly that electric cars can be a competitive source of transport.
Albemarle (ALB.US) has been the largest supplier of lithium for electric vehicle batteries since 2020. Lithium prices are a key factor in the company's profitability - sentiment around its shares has deteriorated as they have fallen. Albemarle also specialises in niche chemical services (bromine, catalysts) but lithium accounted for 68% of its revenues in 2022. The company has issued optimistic forecasts for 2023 and expects demand to improve. The main risks appear to be the spectre of a financial crisis, tighter credit conditions for consumers and potential geopolitical risks arising from strained Washington-Beijing relations. The company has a manufacturing facility in China.
New plant and further higher demand?
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appAlbemarle will invest US$1.3bn in a new lithium processing plant in the US, securing a domestic supply chain for the strategic raw material. According to the company, the plant will double its lithium processing capacity and help serve major customers (including Tesla, TSLA.US) who are reporting higher demand for batteries. The South Carolina plant will be able to process 50,000 tonnes of lithium per year (approximately 2.4 million EVs per year).The company sees the US as a major area for expansion thanks to, among other things, tax credits for electric cars. Construction of the giant project is expected to begin in late 2024; the company has not yet announced an opening date for the plant.
Despite falling lithium prices, the company expects demand to increase. In Q4 2022, the company's net margin was over 36%. The company aims to almost triple production capacity by 2027. In 2022, it reported revenue and EBITDA growth of 120% and 299% y-o-y, respectively. For the current year, Albemarle estimates significant sales growth in the range of 55% - 75% and operating cash flow of US$2.2bn. Despite business growth, the company's shares are still trading at attractive fundamental valuation ratios, at a discount to the average for US equities. P/E is 8 (Nasdaq average 19), C/Wk around 3 (Nasdaq average 4). 
Lithium prices have fallen since Q4 2022 but higher EV sales in China have increased and may support a rebound. Source: Bloomberg
Lithium prices have fallen from a peak reached in late 2022 but still have long-term potential for a rebound. Source: Bloomberg
Albemarle (ALB.US) share chart, D1 interval. The price has settled below the 38.2 Fibonacci retracement of upward wave started in march 2020 and now is trading below the SMA200 and SMA100. However fundamental valuation ratios contrary to technical analysis suggest that the current valuation of the company's business may be much more attractive. The PEG ratio is 0.6 against an average of 2.1 for the US chemical industry. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
